Effectuation as Ineffectual? Applying the 3E Theory-Assessment Framework to a Proposed New Theory of Entrepreneurship

Effectuation is a proposed new theory of entrepreneurship, with insufficient empirical testing and critical analysis. Drawing on a new, comprehensive set of theory-building criteria—sourced from and complementing those of Robert Dubin and others—we provide the first formal assessment of effectuation as a theory. We highlight its strengths and weaknesses, leveraging the former to address the latter in five different directions that would build on the existing work to improve this theory. The assessment exercise also displays the value of our assessment framework in guiding the evaluation and development of other existing and future theories in entrepreneurship and management

Effectuation, Not Being Pragmatic or Process Theorizing, Remains Ineffectual: Responding to the Commentaries

We appreciate the opportunity to respond to the provocative Dialogue pieces of Read, Sarasvathy, Dew, and Wiltbank (2016; henceforth, “RSDW”); Reuber, Fischer, and Coviello (2016; henceforth, “RFC”); Gupta, Chiles, and McMullen (2016; henceforth, “GCM”); and Garud and Gehman (2016; henceforth, “GG”), each of which makes several claims in defense of effectuation, as well as describes several ways forward in entrepreneurship- and process-related theorizing. We respond in a manner consistent with the traditional perspective in management theorizing that “good theory is practical” (Lewin, 1945), where “theory is theory” (Simon, 1967; Van de Ven, 1989) based on our discipline’s collective commitment to knowledge production (Suddaby, 2014). In fact, we respond in the tradition of scientific theory—its building, its critique, and its defense. Leveraging the logic behind that tradition, we thus refute every point contained in RSDW’s, RFC’s, GCM’s, and GG’s commentaries and attempt to build on what is common to all theory while celebrating what is valuable in the diversity of theorizing (i.e., in the ways we produce theory)

Political parties and democratic consolidation in post-communist societies

Political parties have a central role to play in democratic consolidation, yet we know comparatively little about how effectively they represent social cleavages in newly emerging democracies. Using the Lipset–Rokkan framework, this article examines the role of parties in articulating social cleavages in 14 established and 6 emerging democracies using the Comparative Study of Electoral Systems datasets. The results show that the social cleavages in the emerging democracies are similar to those of the established democracies, with religion and class predominating. Parties appear to be less effective in representing social cleavages in the emerging than in the established democracies

Political Contest and Oppositional Voices in Postconflict Democracy:The Impact of Institutional Design on Government–Media Relations

The media are considered to play a crucial democratic role in the public sphere through representing political issues to the public (Gelders et al. 2007); facilitating deliberation, public opinion formation and political participation (Habermas 1989); acting as the 'watchdog' of powerful societal institutions (Norris 2000); and in assisting in the development of civil society in politically fragile and divided contexts (Taylor 2000). Journalists are expected to perform their news reporting within the framework of public interest values, such as objectivity, impartiality, public service, autonomy, and a critical questioning of power (Street 2001). Yet, it is acknowledged that political, cultural, organisational, economic, and relational factors affect this journalistic ideal (Davis 2010). In deeply divided, post-conflict societies, ethno-political antagonisms are fundamental to almost all aspects of civic life, yet there is limited research into how government-media relations operate in such contexts. Most media-politics studies focus on Western majoritarian parliamentary or presidential systems - that is, any system that has clear ‘winners’ and ‘losers’ after elections - and where institutional factors are considered, the focus is largely on how party systems impact on journalism (e.g. Çarkoğlu et al. 2014; Hallin and Mancini 2004; Sheafer and Wolfsfeld 2009). This focus however, neglects important institutional variables, such as mandatory coalition, proportionality and special cross-community voting arrangements, which pertain in more constitutionally complex democracies and which may have a significant impact on media-politics relations

Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

n/

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction:Results from the POPular Genetics Trial

INTRODUCTION: The POPular Genetics trial demonstrated that a CYP2C19 genotype-guided P2Y12 inhibitor strategy reduced bleeding rates compared with standard treatment with ticagrelor or prasugrel without increasing thrombotic event rates after primary percutaneous coronary intervention (PCI). OBJECTIVE: In this analysis, we aimed to evaluate the cost effectiveness of a genotype-guided strategy compared with standard treatment with ticagrelor or prasugrel. METHODS: A 1-year decision tree based on the POPular Genetics trial in combination with a lifelong Markov model was developed to compare costs and quality-adjusted life-years (QALYs) between a genotype-guided and a standard P2Y12 inhibitor strategy in patients with myocardial infarction undergoing primary PCI. The cost-effectiveness analysis was conducted from a Dutch healthcare system perspective. Within-trial survival and utility data were combined with lifetime projections to evaluate lifetime cost effectiveness for a cohort of 1000 patients. Costs and utilities were discounted at 4 and 1.5%, respectively, according to Dutch guidelines for health economic studies. Besides deterministic and probabilistic sensitivity analyses, several scenario analyses were also conducted (different time horizons, different discount rates, equal prices for P2Y12 inhibitors, and equal distribution of thrombotic events between the two strategies). RESULTS: Base-case analysis with a hypothetical cohort of 1000 subjects demonstrated 8.98 QALYs gained and €725,550.69 in cost savings for the genotype-guided strategy (dominant). The deterministic and probabilistic sensitivity analysis confirmed the robustness of the model and the cost-effectiveness results. In scenario analyses, the genotype-guided strategy remained dominant. CONCLUSION: In patients undergoing primary PCI, a CYP2C19 genotype-guided strategy compared with standard treatment with ticagrelor or prasugrel resulted in QALYs gained and cost savings. TRIAL REGISTRATION: Clinicaltrials.gov number: NCT01761786, Netherlands trial register number: NL2872

The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: A randomized controlled trial - BARTrial

Background and Objective: High bilirubin/albumin (B/A) ratios increase the risk of bilirubin neurotoxicity. The B/A ratio may be a valuable measure, in addition to the total serum bilirubin (TSB), in the management of hyperbilirubinemia. We aimed to assess whether the additional use of B/A ratios in the management of hyperbilirubinemia in preterm infants improved neurodevelopmental outcome. Methods: In a prospective, randomized controlled trial, 615 preterm infants of 32 weeks' gestation or less were randomly assigned to treatment based on either B/A ratio and TSB thresholds (consensus-based), whichever threshold was crossed first, or on the TSB thresholds only. The primary outcome was neurodevelopment at 18 to 24 months' corrected age as assessed with the Bayley Scales of Infant Development III by investigators unaware of treatment allocation. Secondary outcomes included complications of preterm birth and death. Results: Composite motor (100±13 vs. 101±12) and cognitive (101±12 vs. 101±11) scores did not differ between the B/A ratio and TSB groups. Demographic characteristics, maximal TSB levels, B/A ratios, and other secondary outcomes were similar. The rates of death and/or severe neurodevelopmental impairment for th

Periodontal status of rheumatoid arthritis patients in khartoum state

<p>Abstract</p> <p>Background</p> <p>Few studies have investigated the periodontal condition among Rheumatoid arthritis in Sudan. The present study described the periodontal condition among Sudanese patients suffering from rheumatoid arthritis and to compare them with those of non-rheumatic subjects.</p> <p>Methods</p> <p>A group of eighty rheumatoid arthritis patients was selected from Patient's Rheumatoid Clinics in Khartoum State during the period of January to May 2010. A control group of eighty patients with the same age and gender was selected for the study. Both Rheumatoid arthritis patients and the control group were examined for their plaque index, gingival index, and clinical attachment loss.</p> <p>Results</p> <p>The results revealed that there were no significant differences in plaque and gingival index among study and control groups, with mean plaque index of (1.25 ± 0.4) for patients and (1.17 ± 0.28) for the control group (p-value is 0.3597). The mean gingival index was (1.2 ± 0.24) for the patients and (1.2 ± 0.33) for the control (p = is 0.3049). The results showed statistically significant differences in clinical attachment loss between study and control groups, with mean clinical attachment loss of (1.03 ± 0.95) for the study group and (0.56 ± 0.63) for the control group (p = 0.0002). The study revealed that no association exists between the type of drug used to treat rheumatoid arthritis (NSAIDs & DMARDs) and the periodontal parameters (plaque index, gingival index, and clinical attachment loss).</p> <p>Conclusion</p> <p>A significant relationship between periodontal disease and Rheumatoid Arthritis does exist, but no difference between plaque and gingival index has been detected among study and control groups.</p

Whole Genome Sequence-Based Analysis of a Model Complex Trait, High Density Lipoprotein Cholesterol

We describe initial steps for interrogating whole genome sequence (WGS) data to characterize the genetic architecture of a complex trait, such as high density lipoprotein cholesterol (HDL-C). We estimate that common variation contributes more to HDL-C heritability than rare variation, and screening for Mendelian dyslipidemia variants identified individuals with extreme HDL-C. WGS analyses highlight the value of regulatory and non-protein coding regions of the genome in addition to protein coding regions